Extended Data Fig. 2: The effect of different heart failure therapies tested in specific trials aiming to recruit HFpEF patients. | Nature Medicine

Extended Data Fig. 2: The effect of different heart failure therapies tested in specific trials aiming to recruit HFpEF patients.

From: Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved

Extended Data Fig. 2

Known and estimated treatment effects for the composite endpoint of the time to a first event of cardiovascular death or HHF are displayed for the subgroup of patients with LVEF ≥ 50%. Panel A shows treatment effect sizes, and Panel B provide hazard ratios and event rates as are available. CI, confidence interval; CV, cardiovascular; HF, heart failure; HHF, hospitalization for heart failure; HR, hazard ratio; LVEF, left ventricular ejection fraction.

Back to article page